Resumo O estudo analisou o rastreamento do câncer do colo do útero em Minas Gerais, Brasil, quanto ao número de exames realizados anualmente e à cobertura do exame citopatológico. A fonte de dados foi o Sistema de Informação do Câncer do Colo do Útero (SISCOLO). Utilizou-se um estudo de série temporal referente à realização do exame, no período entre 2000-2010, em mulheres de 25 a 59 anos, residentes nesse Estado e usuárias do Sistema Único de Saúde (SUS). Realizaram-se comparações em relação às metas pactuadas para o Programa Viva Mulher para as macrorregiões. Observou-se cobertura inferior à meta pactuada pelo Programa Viva Mulher (63,8%) e à estimada pelos critérios populacionais (66,4%). Em 2000, as macrorregiões que apresentaram maior cobertura em relação às duas metas foram: Triângulo do Norte, Triângulo do Sul e Centro. No ano de 2010, observaram-se mudanças em relação à posição ocupada pelas macrorregiões e melhorias na cobertura. Quanto à meta SUS, as macrorregiões Nordeste, Jequitinhonha e Sul apresentaram as maiores coberturas. As diferenças entre as duas metas avaliadas neste estudo sobre a cobertura da realização do exame de Papanicolau destacam a importância da escolha do critério para estabelecimento de metas.
BackgroundFlow diversion is the first-line treatment for several types of intracranial aneurysms. We report on a large series of patients treated with the Derivo Embolization Device who underwent a 1-year angiographic control follow-up.MethodsWe performed a multicenter retrospective analysis of prospectively collected data, designed to evaluate the clinical and angiographic results of treatment of intracranial aneurysms with the Derivo Flow Diverter. The primary endpoint was complete occlusion of the aneurysm within 12 months, which was evaluated using DSA. The secondary endpoint was the absence of any serious adverse events. Univariate and multivariate logistic regression analyses were performed to analyze the data.ResultsThe study was conducted from December 2016 to September 2019 and enrolled 127 patients with 177 intracranial aneurysms, treated at three different centers. Efficacy at 6 months was 70.1% (122/174) for total occlusion and 87.3% (152/174) for favorable occlusion and, at 12 months, it was 83.3% (145/174) for total occlusion and 97.7% (170/174) for favorable occlusion. Regarding safety concerns, 97.6% (124/127) of patients did not experience severe adverse effects during the follow-up period of 12 months, and there was no procedure-related mortality.ConclusionsThe Derivo Embolization Device, achieving a total occlusion rate of 83.3% and a favorable occlusion rate of 97.7% in a 1-year angiographic control study of 174 aneurysms with minor morbidity and no intervention-related mortality, is a safe and effective treatment for intracranial aneurysms.
In patients with giant incisional hernias, many anatomical and physiological changes turn hernia repair into quite a challenge. The possibility of developing complications as abdominal compartment syndrome after hernioplasty has prompted surgeons to seek for technical options. A tempting alternative is to induce progressive preoperative pneumoperitoneum (PPP) aiming to adapt the organism to an increase in the abdominal content. We describe the case of a patient with giant incisional hernia submitted to PPP. The patient complicated with a very symptomatic pneumomediastinum. Despite being frequently well tolerated, it is important to make a point that the induction of PPP may result in severe complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.